NCT01623609
- Conditions
- Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
- Locations
-
- Research Site London, United Kingdom
Clinical trial condition
Opioid-Induced Constipation
Explore clinical trials studying Opioid-Induced Constipation. Study availability and eligibility vary by location and protocol.
65 public trials
4 recruiting studies
Opioid-Induced Constipation trial results
NCT00984334
- Conditions
- Chemically-Induced Disorders, Chronic Pain, Constipation, +10 more
- Locations
-
- Schmerzzentrum Berlin Berlin, Germany
- Schmerzzentrum Frankfurt Frankfurt, Germany
- Gemeinschaftspraxis Tamm-Albert-Schroter-Uhmann Hanover, Germany
- Gemeinschaftspraxis Loewenstein-Hesselbarth Mainz, Germany
Completed
A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.
NCT01983137
- Conditions
- Chemically-Induced Disorders, Chronic Pain, Constipation, +10 more
- Locations
-
- University Hospital Antwerp (UZA): Antwerp, Belgium
NCT01382797
- Conditions
- Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
- Locations
-
- Alkermes Study Site Mesa, Arizona, United States
- Alkermes Study Site Phoenix, Arizona, United States
- Alkermes Study Site National City, California, United States
- Alkermes Study Site Oceanside, California, United States
NCT01100151
- Conditions
- Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
- Locations
-
- Alkermes Investigational Site Sheffield, Alabama, United States
- Alkermes Investigational Site Anaheim, California, United States
- Alkermes Investigational Site Pasadena, California, United States
- Alkermes Investigational Site Walnut Creek, California, United States